Sarissa Capital Management last night disclosed that it reduced its stake in Alkermes to 4.997%. The stock in early trading is down 6% to $25.90.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ALKS:
- Alkermes reaffirms FY23 adjusted EPS view $1.34-$1.57 consensus $1.52
- Alkermes reports Q2 non-GAAP EPS 57c, consensus 56c
- ALKS Upcoming Earnings Report: What to Expect?
- Alkermes shareholders re-elect all seven company director nominees
- Alkermes shareholders re-elect all company directors, Reuters reports